| Pharmaceutical active ingredients: |
| Diloxanide FuroateMetronidazoleSimethicone |
| Available forms, composition and doses of Aristogyl Plus: |
| Tablets; Oral; Diloxanide Furoate 500 mg; Metronidazole 400 mg; Simethicone 100 mg |
| Aristogyl Plus medical category: |
| Human:AntiamoebicsAntiprotozoal agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| P01AB01 - MetronidazoleP01AC01 - Diloxanide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Aristo Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Metrogyl Compound | Diloxanide Furoate; Metronidazole | Unique Pharmaceutical Laboratories; J.B. Chemicals & Pharmaceuticals |
| Metron-DF | Diloxanide Furoate; Metronidazole | Alkem Laboratories |
| Qugyl | Diloxanide Furoate; Metronidazole | RPG Life Sciences |
| Qugyl-DS | Diloxanide Furoate; Metronidazole | RPG Life Sciences |
| Sprot | Diloxanide Furoate; Metronidazole | Mapra Laboratories |
| Sprot Plus | Diloxanide Furoate; Metronidazole; Simethicone | Mapra Laboratories |
| Tinilox MPS Suspension | Diloxanide Furoate; Simethicone; Tinidazole | Yash Vision |
| Antibic-DF | Diloxanide Furoate; Tetracycline Hydrochloride; Tinidazole | Strassenburg Pharmaceuticals |
| Amebis Forte | Diloxanide Furoate; Tinidazole | Zydus Cadila |
| Entrolate | Diloxanide Furoate; Tinidazole | Stadmed |